Besponsa 00008-0100

Generic: Inotuzumab Ozogamicin

Product NDC

00008-0100

Manufacturer: Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 18, 2017
Listing Expires: December 31, 2027
Application: BLA761040

Need to source Besponsa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Inotuzumab Ozogamicin	.25 mg/mL

Drug Class

CD22-directed Immunoconjugate [EPC]CD22-directed Antibody Interactions [MoA]CD22-directed Immunoconjugate [EPC]

Packaging Options(1)

00008-0100-01

1 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01) / 4 mL in 1 VIAL, SINGLE-DOSE

View →